Dr. Gregory Day, MD

• Neurology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN), 2023-07-10

• Prevalence of Surgical Procedures at Symptomatic Onset of Prion Disease Prevalence of Surgical Procedures at Symptomatic Onset of Prion Disease, 2022-03-09

• Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-old, 2022-11-19

• Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease, 2023-08-07

• Life after Autoantibody-Mediated Encephalitis: Optimizing Follow-up and Management in Recovering Patients, 2022-06-01

• CSF tau microtubule-binding region identifies pathological changes in primary tauopathies, 2022-11-24

• Neurocognitive Screening in Patients Following SARS-CoV-2 Infection: Tools for Triage, 2022-02-07

• Avoid or Embrace? Practice Effects in Alzheimer's Disease Prevention Trials, 2022-06-16

• Analysis of Clinical Features, Diagnostic Tests, and Biomarkers in Patients With Suspected Creutzfeldt-Jakob Disease, 2014-2021 Clinical Features, Diagnostic Tests, and Biomarkers in Patients With Suspected Creutzfeldt-Jakob Disease, 2022-08-03

• A Neurologist's Practical Approach to Cognitive Impairment, 2021-11-26

• Anti-amyloid therapies for Alzheimer disease: finally, good news for patients, 2023-06-28

• Searching for Autoimmune Encephalitis: Beware of Normal CSF, 2020-06-05

• Sleep disturbances in patients with autoimmune encephalitis, 2020-06-10

• Leveraging molecular biomarkers to make the common diagnosis in the uncommon patient, 2021-01-07

• Assessing the Reliability of Reported Medical History in Older Adults, 2020-09-02

• Measuring the cognitive costs of the COVID-19 pandemic, 2021-09-23

• Regional age-related atrophy after screening for preclinical alzheimer disease, 2021-09-15

• Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study, 2023-01-06

• Three Cases of Creutzfeldt-Jakob Disease Presenting with a Predominant Dysexecutive Syndrome, 2022-03-01

• Ovarian resection in anti-N-methyl-D-aspartate receptor encephalitis: A comparison of surgical approaches, 2022-11-17

• Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer disease: a cross-sectional study, 2021-09-10

• Covariance-based vs. correlation-based functional connectivity dissociates healthy aging from Alzheimer disease, 2022-07-30

• Clinical and paraclinical measures associated with outcome in cerebral amyloid angiopathy with related inflammation, 2020-12-19

• Alzheimer's Disease Cerebrospinal Fluid Biomarkers Differentiate Patients with Creutzfeldt-Jakob Disease and Autoimmune Encephalitis, 2022-07-05

• Autoimmune Encephalitis Misdiagnosis in Adults Autoimmune Encephalitis Misdiagnosis in Adults, 2022-11-28

• Neurocognitive screening in patients following SARS-CoV-2 infection: tools for triage, 2022-07-30

• Location of pathogenic variants inPSEN1impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease, 2023-06-08

• Sex difference in evolution of cognitive decline: studies on mouse model and the Dominantly Inherited Alzheimer Network cohort, 2023-04-12

• Discovery and validation of dominantly inherited Alzheimer's disease mutations in populations from Latin America, 2022-08-05

• Neurophenotypes of COVID-19: risk factors and recovery outcomes, 2023-02-20

• The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology, 2021-05-21

• Deciphering the Contributions of Neuroinflammation to Neurodegeneration: Lessons from Antibody-Mediated Encephalitis and COVID-19, 2022-04-01